BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15095413)

  • 1. Inhibition of apoptosis and caspase-3 in vascular smooth muscle cells by plasminogen activator inhibitor type-1.
    Chen Y; Kelm RJ; Budd RC; Sobel BE; Schneider DJ
    J Cell Biochem; 2004 May; 92(1):178-88. PubMed ID: 15095413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentation of proliferation of vascular smooth muscle cells by plasminogen activator inhibitor type 1.
    Chen Y; Budd RC; Kelm RJ; Sobel BE; Schneider DJ
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1777-83. PubMed ID: 16709941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of neointimal vascular smooth muscle cellularity in atheroma by plasminogen activator inhibitor type 1 (PAI-1).
    Schneider DJ; Hayes M; Wadsworth M; Taatjes H; Rincón M; Taatjes DJ; Sobel BE
    J Histochem Cytochem; 2004 Aug; 52(8):1091-9. PubMed ID: 15258185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
    Samarakoon R; Higgins CE; Higgins SP; Kutz SM; Higgins PJ
    J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitization of vascular smooth muscle cell to TNF-alpha-mediated death in the presence of palmitate.
    Rho MC; Ah Lee K; Mi Kim S; Sik Lee C; Jeong Jang M; Kook Kim Y; Sun Lee H; Hyun Choi Y; Yong Rhim B; Kim K
    Toxicol Appl Pharmacol; 2007 May; 220(3):311-9. PubMed ID: 17399759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation by fibrates of plasminogen activator inhibitor type-1 expression in human arterial smooth muscle cells.
    Nordt TK; Lutzi S; Ruef J; Peter K; Klar E; Kübler W; Sobel BE; Bode C
    Thromb Haemost; 2001 Nov; 86(5):1305-13. PubMed ID: 11816722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maspin sensitizes breast carcinoma cells to induced apoptosis.
    Jiang N; Meng Y; Zhang S; Mensah-Osman E; Sheng S
    Oncogene; 2002 Jun; 21(26):4089-98. PubMed ID: 12037665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of plasminogen activator inhibitor type 1 on apoptosis.
    Schneider DJ; Chen Y; Sobel BE
    Thromb Haemost; 2008 Dec; 100(6):1037-40. PubMed ID: 19132227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiproliferative agents alter vascular plasminogen activator inhibitor-1 expression: a potential prothrombotic mechanism of drug-eluting stents.
    Muldowney JA; Stringham JR; Levy SE; Gleaves LA; Eren M; Piana RN; Vaughan DE
    Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):400-6. PubMed ID: 17158352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rac-1 promotes pulmonary artery smooth muscle cell proliferation by upregulation of plasminogen activator inhibitor-1: role of NFkappaB-dependent hypoxia-inducible factor-1alpha transcription.
    Diebold I; Djordjevic T; Hess J; Görlach A
    Thromb Haemost; 2008 Dec; 100(6):1021-8. PubMed ID: 19132225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of apoptosis in vascular cells by plasminogen activator inhibitor-1 and high molecular weight kininogen correlates with their anti-adhesive properties.
    Al-Fakhri N; Chavakis T; Schmidt-Wöll T; Huang B; Cherian SM; Bobryshev YV; Lord RS; Katz N; Preissner KT
    Biol Chem; 2003 Mar; 384(3):423-35. PubMed ID: 12715893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential mechanisms of plasminogen activator inhibitor-1 gene activation by transforming growth factor-beta and tumor necrosis factor-alpha in endothelial cells.
    Chen YQ; Sloan-Lancaster J; Berg DT; Richardson MA; Grinnell B; Tseng-Crank J
    Thromb Haemost; 2001 Dec; 86(6):1563-72. PubMed ID: 11776328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activator inhibitor-1 and vitronectin expression level and stoichiometry regulate vascular smooth muscle cell migration through physiological collagen matrices.
    Garg N; Goyal N; Strawn TL; Wu J; Mann KM; Lawrence DA; Fay WP
    J Thromb Haemost; 2010 Aug; 8(8):1847-54. PubMed ID: 20492459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhein inhibits TNF-alpha-induced human aortic smooth muscle cell proliferation via mitochondrial-dependent apoptosis.
    Heo SK; Yun HJ; Park WH; Park SD
    J Vasc Res; 2009; 46(4):375-86. PubMed ID: 19142017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
    Song Y; Shen K; Yu JR
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator inhibitor-1 modulates adipocyte differentiation.
    Liang X; Kanjanabuch T; Mao SL; Hao CM; Tang YW; Declerck PJ; Hasty AH; Wasserman DH; Fogo AB; Ma LJ
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E103-E113. PubMed ID: 16144810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activator inhibitor-1 deficiency enhances flow-induced smooth muscle cell migration.
    Cullen JP; Nicholl SM; Sayeed S; Sitzmann JV; Okada SS; Cahill PA; Redmond EM
    Thromb Res; 2004; 114(1):57-65. PubMed ID: 15262486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melittin inhibits vascular smooth muscle cell proliferation through induction of apoptosis via suppression of nuclear factor-kappaB and Akt activation and enhancement of apoptotic protein expression.
    Son DJ; Ha SJ; Song HS; Lim Y; Yun YP; Lee JW; Moon DC; Park YH; Park BS; Song MJ; Hong JT
    J Pharmacol Exp Ther; 2006 May; 317(2):627-34. PubMed ID: 16401728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells.
    Sun SY; Yue P; Hong WK; Lotan R
    Cancer Res; 2000 Dec; 60(24):7149-55. PubMed ID: 11156424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different structural requirements for plasminogen activator inhibitor 1 (PAI-1) during latency transition and proteinase inhibition as evidenced by phage-displayed hypermutated PAI-1 libraries.
    Stoop AA; Eldering E; Dafforn TR; Read RJ; Pannekoek H
    J Mol Biol; 2001 Jan; 305(4):773-83. PubMed ID: 11162091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.